Cetera Investment Advisers’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21M | Sell |
95,270
-3,500
| -4% | -$968K | 0.02% | 733 |
|
|
2026
Q1 | $29.2M | Buy |
98,770
+17,164
| +21% | +$5.1M | 0.03% | 546 |
|
|
2025
Q4 | $22.3M | Buy |
81,606
+17,140
| +27% | +$4.66M | 0.02% | 624 |
|
|
2025
Q3 | $17.4M | Buy |
64,466
+22,836
| +55% | +$6.21M | 0.02% | 707 |
|
|
2025
Q2 | $11.5M | Buy |
41,630
+1,434
| +4% | +$390K | 0.02% | 757 |
|
|
2025
Q1 | $10.7M | Buy |
40,196
+6,319
| +19% | +$1.56M | 0.02% | 737 |
|
|
2024
Q4 | $7.87M | Buy |
33,877
+2,006
| +6% | +$461K | 0.02% | 817 |
|
|
2024
Q3 | $7.03M | Sell |
31,871
-10,290
| -24% | -$2.13M | 0.02% | 837 |
|
|
2024
Q2 | $8.29M | Sell |
42,161
-5,360
| -11% | -$1.11M | 0.02% | 750 |
|
|
2024
Q1 | $10.2M | Buy |
47,521
+38,540
| +429% | +$8.1M | 0.02% | 667 |
|
|
2023
Q4 | $1.89M | Sell |
8,981
-919
| -9% | -$196K | 0.02% | 822 |
|
|
2023
Q3 | $1.98M | Buy |
9,900
+623
| +7% | +$124K | 0.02% | 753 |
|
|
2023
Q2 | $1.72M | Sell |
9,277
-43
| -0.5% | -$7.95K | 0.01% | 835 |
|
|
2023
Q1 | $1.78M | Buy |
9,320
+651
| +8% | +$118K | 0.02% | 787 |
|
|
2022
Q4 | $1.46M | Buy |
8,669
+5,082
| +142% | +$883K | 0.01% | 826 |
|
|
2022
Q3 | $635K | Sell |
3,587
-112
| -3% | -$22.1K | 0.01% | 892 |
|
|
2022
Q2 | $757K | Buy |
3,699
+214
| +6% | +$45.4K | 0.01% | 900 |
|
|
2022
Q1 | $829K | Buy |
3,485
+190
| +6% | +$44.6K | 0.01% | 882 |
|
|
2021
Q4 | $753K | Buy |
3,295
+78
| +2% | +$17.2K | 0.01% | 940 |
|
|
2021
Q3 | $622K | Buy |
3,217
+153
| +5% | +$31K | 0.01% | 1013 |
|
|
2021
Q2 | $652K | Buy |
3,064
+379
| +14% | +$80K | 0.01% | 970 |
|
|
2021
Q1 | $549K | Sell |
2,685
-141
| -5% | -$27.8K | 0.01% | 923 |
|
|
2020
Q4 | $514K | Buy |
2,826
+1,361
| +93% | +$231K | 0.01% | 942 |
|
|
2020
Q3 | $245K | Sell |
1,465
-13
| -0.9% | -$2.19K | 0.02% | 542 |
|
|
2020
Q2 | $240K | Buy |
1,478
+12
| +0.8% | +$2.15K | 0.02% | 534 |
|
|
2020
Q1 | $253K | Sell |
1,466
-295
| -17% | -$58.7K | 0.03% | 436 |
|
|
2019
Q4 | $352K | Buy |
1,761
+93
| +6% | +$19.1K | 0.04% | 420 |
|
|
2019
Q3 | $351K | Buy |
1,668
+55
| +3% | +$11.5K | 0.04% | 372 |
|
|
2019
Q2 | $312K | Buy |
1,613
+166
| +11% | +$30.6K | 0.04% | 379 |
|
|
2019
Q1 | $239K | Buy |
1,447
+350
| +32% | +$61.9K | 0.03% | 413 |
|
|
2018
Q4 | $205K | Sell |
1,097
-292
| -21% | -$53.9K | 0.03% | 418 |
|
|
2018
Q3 | $236K | Buy |
+1,389
| New | +$234K | 0.03% | 424 |
|
|
2018
Q1 | – | Sell |
-1,561
| Closed | -$228K | – | 394 |
|
|
2017
Q4 | $228K | Buy |
+1,561
| New | +$222K | 0.04% | 365 |
|
Other funds holding CME
Cetera Investment Advisers's CME Position: Q2 2026 in Review
Cetera Investment Advisers reduced its CME Group (CME) stake by 3.5% in Q2 2026, selling an estimated $968K and leaving 95,270 shares worth $21M. The position accounts for 0.02% of the portfolio, ranked #733.
Cetera Investment Advisers first reported a position in CME in Q4 2017 and has held it in 33 quarters since. The position peaked at $29.2M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Cetera Investment Advisers held 95,270 shares of CME Group worth $21M as of Q2 2026.
- Cetera Investment Advisers sold 3,500 CME Group shares in Q2 2026, an estimated $968K.
- CME Group made up 0.02% of Cetera Investment Advisers's portfolio in Q2 2026, its #733 holding.
- Cetera Investment Advisers first reported a position in CME Group in Q4 2017 and has held it in 33 quarters since.
- Cetera Investment Advisers's CME Group position peaked at $29.2M in Q1 2026.
- 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.